Review decision date: April 2014
This guideline should not be updated at this time. For further information, please refer to the Surveillance Review Decision.
Please note that the 8-year surveillance review did not include consideration of the section of the guideline on progestogen-only subdermal implant. This section of the guideline at the time of the surveillance review was in the process of being updated by the guideline updates standing committee. This addendum update was subsequently published on 03 September 2014.
Next review date: 2017
The NICE guideline on long-acting reversible contraception (LARC) offers best-practice advice for all women of reproductive age who may wish to regulate their fertility using LARC methods. It covers specific issues for the use of these methods during the menarche and before the menopause, and by particular groups, including women who have HIV, learning disabilities or physical disabilities, or are younger than 16 years.
The guideline was previously called long-acting reversible contraception (update).
The addendum to NICE guideline CG30 updates the recommendations on progestogen-only subdermal implants in section 1.5 of the guideline. The addendum also contains details of the methods and evidence used to update these recommendations. The progestogen-only subdermal implant Implanon, previously recommended in this guideline, is no longer available and has been replaced by Nexplanon. Nexplanon contains the same amount of the same drug as Implanon, but the summaries of product characteristics for the two devices are not identical.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.